SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-020055
Filing Date
2022-05-27
Accepted
2022-05-27 21:27:42
Documents
1
Period of Report
2022-05-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6629
  Complete submission text file 0000899243-22-020055.txt   8217
Mailing Address C/O PDL BIOPHARMA, INC. 932 SOUTHWOOD BOULEVARD INCLINE VILLAGE NV 89451
Business Address
MCLAUGHLIN JOHN PETER (Reporting) CIK: 0001277967 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39473 | Film No.: 22980140

Mailing Address 2800 DISCOVERY DRIVE SUITE 100 ORLANDO FL 32826
Business Address 2800 DISCOVERY DRIVE SUITE 100 ORLANDO FL 32826 888-536-7271
LENSAR, Inc. (Issuer) CIK: 0001320350 (see all company filings)

IRS No.: 320125724 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus